Mar 22 • 04:30 UTC 🇪🇸 Spain El País

Meloni faces the first serious risk of defeat in three years with a controversial referendum

Italy is voting on a controversial referendum to reform the judiciary, posing a significant challenge to Prime Minister Giorgia Meloni.

Italy is currently holding a controversial referendum on judiciary reforms that some polls suggest could lead to a significant defeat for Prime Minister Giorgia Meloni. This referendum is unusual, as it is being viewed not only as a vote on judicial reforms but as a plebiscite regarding Meloni's leadership during her first three and a half years in office. Until now, Meloni has been largely unchallenged, and her government has not faced significant opposition or 'wear and tear' from the electorate. However, the looming possibility of a 'no' vote has raised concerns and unrest within her administration.

Meloni has insisted that she will not resign if the 'no' vote prevails and has claimed that the referendum is not about her government; however, this assertion has done little to quell public apprehension. Many voters see the referendum as a critical moment not just for judicial reform but for assessing the confidence in her government, particularly as it comes just a year and a half ahead of the next set of elections, scheduled for September 2027. The mounting pressure is reflected in her recent rhetoric, which has shifted towards more contentious and populist framing as she attempts to galvanize her support base.

The outcome of this referendum could have substantial implications for Meloni's political future and her party's standing. A defeat might embolden opposition parties and challenge her authority as Prime Minister, making it difficult to implement her political agenda going forward. With the potential to rethink judicial powers and approach, the referendum acts as a litmus test for citizen sentiment toward her government and its policies, signaling whether her administration can sustain the confidence of the Italian populace in the long term.

📡 Similar Coverage